Articles tagged with “MADRS”
An in-depth clinical guide examining the evidence for low-dose ketamine in the treatment of major depressive disorder and treatment-resistant depression. Covers mechanisms of action, clinical trial data, response predictors, duration of effect, maintenance strategies, and cost-benefit analysis.
How is ketamine response actually measured? A review of validated depression scales, suicidality tools, functional assessments, and biomarkers used in trials.
Send corrections, provider questions, or advertising inquiries.
